About
This app is designed for patients participating in clinical trials to report outcomes. Users require an account provided by a clinical trial site to access and log their data.
What's New in Teva_TV56286
2.15.6 (66)
October 31, 2026
Addition of optional Handheld Training Module
Developer apps
FAQ
What is Teva_TV56286-NDG-20039 used for?
Teva_TV56286-NDG-20039 is an eCOA (electronic clinical outcome assessment) app designed for patients to report outcomes related to a clinical trial. It allows for the collection of patient-reported data during research studies.
How do I get an account for Teva_TV56286-NDG-20039?
You cannot create an account for Teva_TV56286-NDG-20039 on your own. Patients must be given login credentials by a participating clinical trial site to access the app.
Is Teva_TV56286-NDG-20039 free to use?
Yes, Teva_TV56286-NDG-20039 is available for free. There are no costs associated with downloading or using the application itself.
What devices does Teva_TV56286-NDG-20039 support?
Teva_TV56286-NDG-20039 is supported on iPhone, iPad, and iPod devices. This ensures accessibility for a range of Apple mobile users.
What is the age rating for Teva_TV56286-NDG-20039?
The app has an age rating of 12+, making it suitable for users aged 12 and older. This rating is based on content and intended use.
How often is Teva_TV56286-NDG-20039 updated?
The latest version of Teva_TV56286-NDG-20039 is 2.15.5 (60), released on December 4, 2025. Updates are provided periodically to improve functionality and address any issues.
What is the user feedback on Teva_TV56286-NDG-20039?
Based on available data, Teva_TV56286-NDG-20039 has a rating of 2.0 stars from 1 rating. This indicates a low user satisfaction score from the limited feedback received.
Does Teva_TV56286-NDG-20039 have ads?
No, Teva_TV56286-NDG-20039 does not contain advertisements. The app is ad-free, ensuring an uninterrupted experience for patients reporting their outcomes.










